Pasar al contenido principal

NUEVAS TERAPIAS DIRIGIDAS FRENTE A NEUROBLASTOMA MEDIANTE LA INHIBICION ESPECIFICA DE C-MYC Y N-MYC (INVESTIGACION SOBRE MYC PARA FUTURAS TERAPIAS)

PID2024-160408OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Zinc cofactor in human histone deacetylase 8: Requirement for function and opportunity for drug discovery

  • Garcia-Franco, Paula M.
  • Falcó-Martí, F. Javier
  • Jeblaoui, Hajar
  • Asencio del Rio, Marta
  • Ortega-Alarcon, David
  • Vega, Sonia
  • Galano-Frutos, Juan J.
  • Abian, Olga
  • Velazquez-Campoy, Adrian
HDAC8 (histone deacetylase 8), a class I HDAC, is a promising target for different disorders: X-linked intellectual disability, fibrotic disease, cancer, and several neuropathological diseases. The structural and functional similarity between HDACs hinders the development of selective HDAC8 inhibitors. To date, no drugs based on competitive inhibition have been approved. In order to identify weaknesses in HDAC8 amenable to drug discovery, we report here a comprehensive thermodynamic characterization of the structural stability and its modulation by the interaction with its zinc (Zn2+) cofactor using a combination of experimental and computational techniques. HDAC8 represents an interesting example of an allosteric protein in the broad sense, in which its cofactor, the zinc ion, modulates its conformational equilibrium. The native, inactive, zinc-free state is physiologically relevant considering that the intracellular concentration of zinc is very low and may constitute a valid target for drug discovery.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella

  • Jiménez-Alesanco, Ana
  • Gómara-Lomero, Marta
  • Jeblaoui, Hajar
  • Vega, Sonia
  • Velázquez-Campoy, Adrián
  • Aínsa, José Antonio
  • Abián, Olga
Bacteroides fragilis is a key component of the human gut microbiota, although enterotoxigenic strains (ETBF), which produce B. fragilis toxin (BFT), can act as opportunistic pathogens. BFT disrupts intestinal epithelial integrity and contributes to conditions such as inflammatory bowel disease and colorectal cancer. This study aimed to characterize three allosteric inhibitors of BFT-3 (isoform 3 of BFT), previously identified by our group through high-throughput screening of US Food and Drug Administration approved drugs. We evaluated their activities in vitro and in vivo. Using Galleria mellonella larvae as a novel infection model for B. fragilis, we assessed the antimicrobial and antivirulence potential of these compounds. Among the three tested compounds, MOA4 demonstrated superior efficacy, enhanced bacterial clearance in vivo, and increased larval survival in a dose-dependent manner, with minimal toxicity. Synergy studies have revealed the potential combinatory effects of MOA4 and conventional antibiotics. These findings establish G. mellonella as a valuable alternative model for studying B. fragilis infections and highlight MOA4 as a promising candidate to be repurposed for the treatment of B. fragilis-mediated diseases while preserving commensal microbiota.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Citrullination at the Nuclear Localization Signal of the Inhibitor of Growth 4 (ING4) Interferes With its Binding to Importin α3

  • Álvarez-Rodríguez, María Gabriela
  • Vega, Sonia
  • Hornos, Felipe
  • Fienco-Bacusoy, Augusto
  • Abian, Olga
  • Velazquez-Campoy, Adrian
  • Rizzuti, Bruno
  • Neira, José L.
The inhibitor of growth 4 (ING4) acts as a tumor suppressor regulating chromatin structure. Due to this nuclear function, ING4 has a nuclear localization signal (NLS), which is recognized by the cellular translocation machinery ‒ mainly formed by proteins named importins, which include the isoform importin α3 (Impα3) ‒ to allow movement through the nuclear membrane. Peptidyl arginine iminohydrolases (PADIs) are enzymes involved in the posttranslational modification of arginine to citrulline. PADI4, one of the five isoforms of PADI in humans, citrullinates ING4 at the NLS region. We studied in vitro and in silico how the different degrees of citrullination affected binding of the NLS of ING4 to PADI4, Impα3 and its truncated species (ΔImpα3), lacking the importin binding domain, by using several biophysical techniques and molecular simulations. To that end, we synthesized eight peptides encompassing the NLS of ING4 (residues 130–152), with single, double and triple citrulline replacements at Arg132, Arg142 and Arg144. The peptides were monomeric and disordered, as tested by DOSY, 1D- and 2D-1H NMR experiments. All the peptides were capable of binding to PADI4 with low micromolar affinities, but their affinity decreased as the fraction of citrullination increased. Moreover, all peptides could bind to both importin species with affinities in the low micromolar range, and their affinities were also dependent on the citrullination degree. The peptides targeted the canonical NLS binding site for cargo proteins of both importin species. These findings suggest that: (i) citrullination at the NLS might interfere with ING4 nuclear translocation; and (ii) successive citrullination at the NLS affected binding to PADI4.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Unfolding Behavior and Conformational Changes Under Different Denaturing Conditions of MAPK 1 (MEK1)

  • Álvarez-Rodríguez, Maria Gabriela
  • Vega, Sonia
  • Hornos, Felipe
  • Velazquez-Campoy, Adrian
  • Rizzuti, Bruno
  • Neira, José L.
Protein kinases have key roles in cells as they regulate diverse signal transduction pathways. Mitogen-activated protein kinase (MAPK) signaling route modulates several processes, such as cell proliferation, cell programming, metabolic changes and stress responses. Within the group of proteins participating in this pathway, the MAPK kinase (MEK1) is a dimeric, 393-residue-long, dual-specificity protein kinase that phosphorylates both tyrosine and threonine residues. In this study, we explored the conformational changes occurring during the unfolding of MEK1, by using orthogonal biophysical techniques. Intrinsic fluorescence, extrinsic 8-anilinonapthalene-1-sulfonic acid (ANS) fluorescence, dynamic light scattering (DLS), and far-ultraviolet (UV) circular dichroism (CD) showed that the protein acquired a native-like conformation within a narrow pH range (8.0 to 9.0). Urea and guanidinium hydrochloride (GdmCl) denaturations followed by intrinsic and ANS fluorescence and far-UV CD, at pH 8.1, where the protein acquired a native-like conformation, showed that: (i) the apparent conformational stability of isolated MEK1 was low; and (ii) the unfolding occurred through the presence of intermediates. The presence of several unfolding intermediates was also evidenced through: (i) differential scanning calorimetry (DSC) in the absence of the ligand ATP; and (ii) unfolding simulations with the help of computational techniques based on constraint network analysis (CNA). We propose that the apparent low stability of this protein was related to its flexibility and modulates its ability to interact with diverse molecular partners.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Citrullination in proteins of the polycomb repressor complex 1

  • Álvarez-Rodríguez, María Gabriela
  • Capone, Emanuel
  • Vega, Sonia
  • Rejas, Virginia
  • Rizzuti, Bruno
  • Velazquez-Campoy, Adrian
  • Neira, José L.
The Polycomb repressive complexes can be considered a paradigm of chromatin-based gene regulation in animals. Two of the proteins involved in such complexes are the Ring finger protein 1 (RING1) and the intrinsically disordered protein RING1A and YY1 binding protein (RYBP), which binds to RING1 in some of the Polycomb complexes. Peptidyl arginine iminohydrolases (PADIs) are enzymes involved in the post-translational modification of arginine to citrulline. PADI4, one of the five isoforms of PADI in humans, citrullinates RING1B and RYBP at specific arginines at their C-terminal (Arg231) and N-terminal (Arg53) regions, respectively. In this work, we studied in vitro and in silico whether isolated peptides from each protein, encompassing those wild-type arginines and their citrulline-modified counterparts, were capable of binding to PADI4. The isolated peptides, either in wild-type or modified form, were monomeric and disordered as indicated by far-UV CD and NMR. The affinity constants of peptides for PADI4, as measured by fluorescence, biolayer interferometry (BLI) and isothermal titration calorimetry (ITC), were in the low micromolar range (dissociation constants around 10-20 μM), and the affinities were smaller for the citrullinated variants. Molecular docking simulations showed that the isolated peptides from each protein, either in wild-type form or modified variants, targeted the active site of PADI4, corresponding to the catalytic residue Cys645. These findings suggest that the isolated peptides were capable of binding to the enzyme with affinities similar to those of intact RING1B or RYBP, and that citrullination of the arginines diminished the affinity for the enzyme.